HSF1 and pancreatic neoplasm: This finding is supported by literature data; amplification of HSF1 was shown in a wide variety of tumors with a 10.33–26.54% alteration frequency in the most aggressive tumors, i.e. ovarian epithelial tumors, breast cancer, pancreatic cancer [74, 75].